Literature DB >> 2459575

Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki Disease.

S Nishihara, K Ishibashi, K Iribe, I Matsuda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2459575     DOI： 10.1016/s0140-6736(88)92650-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  IgG levels in Kawasaki disease and its association with clinical outcomes.

Authors:  Marco Antonio Yamazaki-Nakashimada; Luisa Berenise Gámez-González; Chiharu Murata; Takafumi Honda; Kumi Yasukawa; Hiromichi Hamada
Journal:  Clin Rheumatol       Date:  2018-10-20       Impact factor: 2.980

2.  Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas.

Authors:  Fernanda Falcini; Serena Capannini; Donato Rigante
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-20       Impact factor: 3.054

Review 3.  Intravenous immunoglobulin for the treatment of Kawasaki disease in children.

Authors:  R M Oates-Whitehead; J H Baumer; L Haines; S Love; I K Maconochie; A Gupta; K Roman; J S Dua; I Flynn
Journal:  Cochrane Database Syst Rev       Date:  2003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.